抗肿瘤药物临床试验中的医学伦理问题  

Medical Ethical Issues in the Clinical Trials of Anti-Cancer Drugs

作　　者：黄健[1] 王晓稼[1] 

机构地区：[1]浙江省肿瘤医院,浙江杭州310022

出　　处：《中国肿瘤》2015年第10期834-837,共4页China Cancer

摘　　要：随着新型抗肿瘤药物的快速发展和临床应用,特别是临床医学进入了循证医学时代,涉及抗肿瘤新药、不同药物组合或方案、剂量调整等都需要进行临床研究,以证实其有效性与安全性,在研究设计和研究过程的各个阶段均应解决医学伦理问题,只有预见并解决了这些伦理问题,才能保证研究的顺利进行,特别是在方案设计和知情同意方面。With the rapid development of new antitumor drugs and clinical application,especially in the era of evidence-based medicine,the clinical trials involved in novel antitumor drugs,different combinations or scheme,dose adjustment were initiated to confirm its efficacy and safety. During the different stages of the study designing and processing,we should solve all the ethical issues. After foreseeing and solving these ethical issues,especially in the scheme design and informed consent,the clinical trials will process smoothly.

关 键 词：临床试验 医学伦理 抗肿瘤药物 

分 类 号：R197[医药卫生—卫生事业管理]